LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170000815A1
SERIAL NO

15060492

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to composition and methods using lipid formulated siRNA targeted to a PCSK9 gene.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INC675 WEST KENDALL STREET HENRI A TERMEER SQUARE CAMBRIDGE MA 02142-1110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akinc, Akin Needham, US 113 3427
Fitzgerald, Kevin Brookline, US 209 2389
Hinkle, Gregory Plymouth, US 164 786
Milstein, Stuart Cambridge, US 133 755

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation